A document titled "Designed for Low "Likeability" in independent Recreational Opioid Users". The document is divided into three sections. The first section is titled "Clinical Abuse Potential (cap) studies conducted with rigorous opioid extraction methods to reduce particle size". The second section has a list of clinical abuse potential studies conducted by the FDA. The third section has an illustration of a bottle of pills and a magnifying glass. The text on the document explains that the study is focused on reducing particle size and that it is designed to reduce the risk of low-likeability of recreational opioid users. The document also mentions that the FDA is responsible for ensuring that the user is aware of the potential risks associated with the study.

• Advertisement

• Sales and Marketing